Paid More Than 50% of Debt, Heading towards debt free
Debt to equity ratio has decreased and is lowest in last five years
All key Trailing Twelve Months Margin growing by 15 %
Steady View
Piotroski F Score - Stable Value of 5.0
Steady increase in Total Assets for last 3 Years
Book Value in last 3 years is trending up
Good Net Margin of 16.46% is achieved by the company
Risky View
Tsr Value Index - Very Poor Score of 18.06
Tsr Growth Index - Very Poor Score of 14.13
Tsr Profitability Index - Poor Score of 21.88
Stock Returns < -43.89 % Than Nifty in last one year
Stock Returns is less than Nifty returns for consequitive last three years
Operating Cash Flow decreasing for last 3 year
Company is unable to generate enough free cash to support the business.
Terrific Steady Risky Stock View - Fundamental Snapshot
Share Overview
Promoter Owned
48.80 %
Institution Owned
26.00 %
Public/Others
25.20 %
Outstanding Shares
18.26 Cr
Floating Shares
8.43 Cr
Floating / Outstanding
46.20%
Book Value/Share
233.60
Face value
2.00
Share Holding
Annual Key Income Statement of NATCOPHARM
Period
31_Mar_2022
31_Mar_2021
Growth
Net Income From Continuing Ops
170.00
442.40
61.57 %
Net Income
170.00
440.90
61.44 %
Operating Income
103.20
476.00
78.32 %
Total Revenue
1944.80
2052.10
5.23 %
Operating Expense
1841.60
1576.10
16.85 %
Interest Expense
17.70
13.30
33.08 %
Tax Expense
32.20
137.20
76.53 %
Income Before tax
202.20
579.60
65.11 %
Gross Profit
1383.90
1082.40
27.85 %
Dividend Paid
-82.20
-113.90
27.83 %
Quarterly Key Income Statement of NATCOPHARM
Period
30_Sep_2022
30_Jun_2022
Growth
Net Income From Continuing Ops
56.80
320.40
82.27 %
Net Income
56.80
320.40
82.27 %
Operating Income
53.60
355.70
84.93 %
Total Revenue
432.10
884.60
51.15 %
Operating Expense
336.80
528.90
36.32 %
Interest Expense
3.80
4.20
9.52 %
Tax Expense
13.50
65.40
79.36 %
Income Before tax
70.30
385.80
81.78 %
Gross Profit
326.30
736.90
55.72 %
Dividend Paid
-63.90
0
%
Key Balance Sheet Fields
Period
31_Mar_2022
31-Mar-21
Growth
Common Stock
36.50
36.50
0 %
Current Liabilities
710.40
525.60
35.16 %
Total Liabilities
845.50
670.30
26.14 %
Current Assets
2497.20
2337.30
6.84 %
Total Assets
5109.10
4791.90
6.62 %
Working capital
1786.80
1811.70
1.37 %
Accounts Payable
161.80
146.20
10.67 %
Inventory
862.00
798.20
7.99 %
Net Receivable
620.60
412.90
50.30 %
Key Cash Flow Fields
Period
31_Mar_2022
31_Mar_2021
Growth
Cash EPS
17.13
30.65
44.11 %
Cash From Investment Activity
-5.30
-103.30
94.87 %
Cash From Financial Activity
34.80
-185.70
118.74 %
Cash Operational Activity
46.50
298.80
84.44 %
Net Cash Flow
76.00
9.80
675.51 %
NetIncome
170.00
440.90
61.44 %
Capital Expenditure
232.80
254.60
8.56 %
Change To Inventory
56.40
-240.20
123.48 %
About Natco Pharma Limited NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF; and agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. The company markets its products in approximately 50 countries. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.
TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick
TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential
TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value
This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback
We are working on fundamental strength also. Please share your views to help shape up the requirement.
